The rise of China's research: a global opportunity The Lancet +++ +...

The rise of China's research: a global opportunity The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00084-X/fulltext?dgcid=raven_jbs_etoc_email Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial Prof Alexandre Abizaid, MD PhDa,* ∙ Prof Roxana Mehran, MDb,* roxana.mehran@mountsinai.org ∙ Angelo Oliva, MDb,c ∙ Daniel Chamié, MD PhDd,e ∙ Rodolfo Staico, MD PhDd ∙ Prof Fazila Malik, MBBSf ∙ et al https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02157-9/abstract?dgcid=raven_jbs_etoc_feature_lancet The Lancet Commission on improving population health post-COVID-19 Prof Harry Rutter, MB BChira,b hr526@bath.ac.uk ∙ Katharina Wabnitz, Dr medc ∙ Devaki Nambiar, PhDd ∙ Prof Amandine Garde, PhDe ∙ Tim G Benton, PhDf,g ∙ Prof David L Heymann, MDh ∙ et al. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02061-6/fulltext?dgcid=raven_jbs_etoc_feature_lancetcovid26 Jan 17, 2026 Volume 407Number 10525p195-308 https://www.thelancet.com/journals/lancet/issue/vol407no10525/PIIS0140-6736(26)X0003-4